EFFECT ·Filed Apr 13, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed5mo ago SEC9999999995-26-001154
IPO/offering going effective
Actionable Insight • Neutral

Monitor for future prospectus supplements that would signal an actual offering; absence of immediate pricing or sale details means no direct financial impact yet.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
ORKA ▲ +37.50% at T+60d
NEUTRAL call ✓ call won +37.50% · α vs SPY +28.58% · entry $61.38 → $84.40
Entry anchored
Apr 10, 03:59 PM ET
via exchange tick
T+1d
+9.25%
call +9.25% · α +8.04%
$67.06
settled 6mo ago
T+5d
+12.20%
call +12.20% · α +8.91%
$68.87
settled 6mo ago
T+20d
+7.01%
call +7.01% · α -0.72%
$65.68
settled 5mo ago
T+60d
+37.50%
call +37.50% · α +28.58%
$84.40
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Oruka Therapeutics' $1 billion shelf registration (S-3) has become effective, allowing the company to sell common stock, preferred stock, depositary shares, or warrants from time to time. This creates a potential for future dilution, though no immediate offering has been announced.

Key Facts

  • S-3 shelf registration effective as of April 10, 2026
  • Registration allows for up to $1 billion in securities to be offered
  • Securities may include common stock, preferred stock, depositary shares, or warrants
  • Offerings can occur at any time over the next three years, with terms disclosed in future prospectus supplements

Financial Impact

Up to $1 billion in potential future dilution

dilutionequity

Risk Factors

  • Potential share dilution if and when offerings are executed
  • Market perception of equity overhang could pressure stock price

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001154
Document: 9999999995-26-001154-index.html9999999995-26-001154
Document: 9999999995-26-001154.txt9999999995-26-001154
26 reports for ORKA
Performance horizon
100% Hit rate 11 of 11 directional calls best @ T+60▲ +80.05%Jun 1, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$93.55 $89.93▼ −3.87%▼ −6.44%$84.38 (−9.80%)
Sep 1, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$91.63 $91.65▼ −0.02%▼ −0.98%$84.38 (+7.91%)
Aug 28, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$91.15 $92.51▼ −1.50%▼ −1.39%$84.38 (+7.42%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.08 $101.82▼ −9.96%▼ −9.76%$84.38 (−25.38%)
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 6/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Jul 15, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.04 $91.95▲ +10.73%▲ +12.40%$84.38 (+1.61%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 5/10
$85.21 $88.27▲ +3.59%▲ +2.66%$84.38 (−0.97%)
Jun 22, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.40 $92.49▲ +10.90%▲ +9.89%$84.38 (+1.18%)
Showing 10 of 26

US Market Status

Market Open — Closes in 3h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access